These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32683745)

  • 1. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients.
    Wu L; Girgis CM; Cheung NW
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):390-393. PubMed ID: 32683745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
    Riahi S; Sombra LRS; Lo KB; Chacko SR; Neto AGM; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J; Anastasopoulou C
    Endocr Res; 2021; 46(2):45-50. PubMed ID: 33275067
    [No Abstract]   [Full Text] [Related]  

  • 3. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.
    Hayek S; Ben-Shlomo Y; Balicer R; Byrne K; Katz M; Kepten E; Raz I; Roitman E; Zychma M; Barda N
    Diabetes Obes Metab; 2021 Aug; 23(8):1995-2000. PubMed ID: 33822446
    [No Abstract]   [Full Text] [Related]  

  • 4. Newly diagnosed diabetes in patients with mild to moderate COVID-19.
    Sathish T; Chandrika Anton M
    Diabetes Metab Syndr; 2021; 15(2):569-571. PubMed ID: 33706188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients.
    Ilias I; Diamantopoulos A; Pratikaki M; Botoula E; Jahaj E; Athanasiou N; Tsipilis S; Zacharis A; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33466617
    [No Abstract]   [Full Text] [Related]  

  • 6. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics of COVID-19 Patients in a Regional Population With Diabetes Mellitus: The ACCREDIT Study.
    Llanera DK; Wilmington R; Shoo H; Lisboa P; Jarman I; Wong S; Nizza J; Sharma D; Kalathil D; Rajeev S; Williams S; Yadav R; Qureshi Z; Narayanan RP; Furlong N; Westall S; Nair S
    Front Endocrinol (Lausanne); 2021; 12():777130. PubMed ID: 35095757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection.
    Vargas-Vázquez A; Bello-Chavolla OY; Ortiz-Brizuela E; Campos-Muñoz A; Mehta R; Villanueva-Reza M; Bahena-López JP; Antonio-Villa NE; González-Lara MF; Ponce de León A; Sifuentes-Osornio J; Aguilar-Salinas CA
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33593750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The excess insulin requirement in severe COVID-19 compared to non-COVID-19 viral pneumonitis is related to the severity of respiratory failure and pre-existing diabetes.
    Lockhart SM; Griffiths H; Petrisor B; Usman A; Calvo-Latorre J; Heales L; Bansiya V; Mahroof R; Conway Morris A
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00228. PubMed ID: 34268452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients.
    Borges Russo MK; Kowalewski LS; da Natividade GR; de Lemos Muller CH; Schroeder HT; Bock PM; Ayres LR; Cardoso BU; Zanotto C; Schein JT; Rech TH; Crispim D; Canani LH; Friedman R; Leitão CB; Gerchman F; Krause M
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality.
    Alhakak A; Butt JH; Gerds TA; Fosbøl EL; Mogensen UM; Krøll J; Pallisgaard JL; Gislason GH; Torp-Pedersen C; Køber L; Weeke PE
    Diabetes Obes Metab; 2022 Mar; 24(3):499-510. PubMed ID: 34779086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.
    Lane W; Weinrib S; Rappaport J
    Diabetes Technol Ther; 2011 May; 13(5):592-5. PubMed ID: 21406014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
    De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
    BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.
    Phan F; Boussouar S; Lucidarme O; Zarai M; Salem JE; Kachenoura N; Bouazizi K; Charpentier E; Niati Y; Bekkaoui H; Amoura Z; Mathian A; Benveniste O; Cacoub P; Allenbach Y; Saadoun D; Lacorte JM; Fourati S; Laroche S; Hartemann A; Bourron O; Andreelli F; Redheuil A;
    Cardiovasc Diabetol; 2021 Aug; 20(1):165. PubMed ID: 34384426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.
    Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A;
    BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak.
    Catargi B; Cheisson G; Tauveron I; Jacqueminet S; Benhamou D
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):375-379. PubMed ID: 32620420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.